Inventor · disambiguated record
Stephen S. Whitehead
Also filed as: WHITEHEAD STEPHEN · WHITEHEAD STEPHEN S
48 granted patents·6 pending applications·490 citations·filing 1995–2024
98Inventor score
Files withUS HEALTH29WHITEHEAD STEPHEN S6THE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES5THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES2US GOVERNMENT2
Top patents by PatentIndex Score
54 records- 0194USRE46042EDevelopment of dengue virus vaccine componentsUS GOVERNMENT·Filed 2007·Granted Jun 28, 2016·8 cites·14 claims
- 0293US6699476B1Production of recombinant respiratory syncytial viruses expressing immune modulatory moleculesFiled 2000·Granted Mar 2, 2004·46 cites·78 claims
- 0392US7846455B2Attenuated chimeric respiratory syncytial virusUS HEALTH·Filed 2003·Granted Dec 7, 2010·36 cites·11 claims
- 0492US2025236848A1Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2024·Application pending·0 cites
- 0591US9090873B2Development of dengue virus vaccine componentsUS OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2012·Granted Jul 28, 2015·5 cites·19 claims
- 0691US8632782B2Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated regionWHITEHEAD STEPHEN S·Filed 2011·Granted Jan 21, 2014·10 cites·17 claims
- 0791US8075903B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4WHITEHEAD STEPHEN S·Filed 2009·Granted Dec 13, 2011·14 cites·36 claims
- 0890US8337860B2Development of dengue virus vaccine componentsWHITEHEAD STEPHEN S·Filed 2007·Granted Dec 25, 2012·6 cites·14 claims
- 0990US8039003B2Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesisUS HEALTH·Filed 2009·Granted Oct 18, 2011·8 cites·10 claims
- 1090US7744902B2Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genesUS HEALTH·Filed 2005·Granted Jun 29, 2010·7 cites·4 claims
- 1190US7560118B2Attenuated dengue virus comprising mutations in the NS3 geneUS HEALTH·Filed 2006·Granted Jul 14, 2009·8 cites·16 claims
- 1289US12203100B2Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2023·Granted Jan 21, 2025·0 cites·3 claims
- 1389US5821088AUse of gram-positive bacteria to express recombinant proteinsSIGA PHARMACEUTICALS INC·Filed 1995·Granted Oct 13, 1998·98 cites·45 claims
- 1488USRE46631EDengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2013·Granted Dec 12, 2017·7 cites·42 claims
- 1588US7709007B2Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequencesUS HEALTH·Filed 2004·Granted May 4, 2010·18 cites·46 claims
- 1688US7226602B2Development of mutations useful for attenuating dengue viruses and chimeric dengue virusesUS HEALTH·Filed 2003·Granted Jun 5, 2007·17 cites·13 claims
- 1787US7517531B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4US HEALTH·Filed 2004·Granted Apr 14, 2009·17 cites·42 claims
- 1886US8298541B2Live attenuated virus vaccines for La Crosse virus and other BunyaviridaeWHITEHEAD STEPHEN S·Filed 2008·Granted Oct 30, 2012·6 cites·7 claims
- 1986US7662397B2Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genesUS HEALTH·Filed 2005·Granted Feb 16, 2010·4 cites·34 claims
- 2086US6923971B2Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genesUS HEALTH·Filed 2001·Granted Aug 2, 2005·15 cites·81 claims
- 2186US5993824AProduction of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequencesUS HEALTH·Filed 1997·Granted Nov 30, 1999·69 cites·17 claims
- 2285US9884104B2Live attenuated virus vaccines for la crosse virus and other bunyaviridaeUS HEALTH·Filed 2016·Granted Feb 6, 2018·3 cites·9 claims
- 2385USRE46641EDengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2013·Granted Dec 19, 2017·5 cites·36 claims
- 2485US9783787B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4WHITEHEAD STEPHEN S·Filed 2011·Granted Oct 10, 2017·5 cites·9 claims
- 2585USRE45016EDevelopment of mutations useful for attenuating dengue viruses and chimeric dengue virusesUS OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2013·Granted Jul 15, 2014·4 cites·13 claims
- 2684US9707287B2Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural proteinTHE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES·Filed 2013·Granted Jul 18, 2017·3 cites·17 claims
- 2783US11746335B2Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2022·Granted Sep 5, 2023·0 cites·4 claims
- 2882US10058602B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusUS HEALTH·Filed 2014·Granted Aug 28, 2018·3 cites·15 claims
- 2982USRE45053EAttenuated dengue virus comprising mutations in the NS3 geneUS OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH WASHINGTON D C·Filed 2013·Granted Jul 29, 2014·4 cites·16 claims
- 3080US11318196B2Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural proteinUS HEALTH·Filed 2019·Granted May 3, 2022·0 cites·16 claims
- 3179US7842798B2Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccinesUS HEALTH·Filed 2005·Granted Nov 30, 2010·3 cites·15 claims
- 3278US9255252B2Live attenuated virus vaccines for La Crosse virus and other BunyaviridaeWHITEHEAD STEPHEN S·Filed 2012·Granted Feb 9, 2016·2 cites·5 claims
- 3377US6689367B1Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequencesUS HEALTH·Filed 1999·Granted Feb 10, 2004·46 cites·51 claims
- 3476US11753627B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4US HEALTH·Filed 2020·Granted Sep 12, 2023·0 cites·4 claims
- 3576US11400150B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusUS HEALTH·Filed 2020·Granted Aug 2, 2022·0 cites·9 claims
- 3675US7820182B2Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositionsUS HEALTH·Filed 2003·Granted Oct 26, 2010·5 cites·11 claims
- 3775US7465794B2Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory moleculesUS HEALTH·Filed 2004·Granted Dec 16, 2008·4 cites·63 claims
- 3874US11332722B2Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted May 17, 2022·0 cites·6 claims
- 3972US10837003B2Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4US HEALTH·Filed 2017·Granted Nov 17, 2020·0 cites·5 claims
- 4071US10724007B2Development of dengue virus vaccine componentsTHE GOVERNMENT OF THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2018·Granted Jul 28, 2020·0 cites·9 claims
- 4171US8778671B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusPLETNEV ALEXANDER G·Filed 2004·Granted Jul 15, 2014·4 cites·6 claims
- 4270US2020147202A1Live attenuated virus vaccines for la crosse virus and other bunyaviridaeUS HEALTH·Filed 2020·Application pending·0 cites
- 4369US10869920B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusUS HEALTH·Filed 2019·Granted Dec 22, 2020·0 cites·11 claims
- 4469US10561724B2Live attenuated virus vaccines for La Crosse virus and other bunyaviridaeUS HEALTH·Filed 2019·Granted Feb 18, 2020·0 cites·10 claims
- 4568US10500264B2Development of mutations useful for attenuating dengue viruses and chimeric dengue virusesUS HEALTH·Filed 2017·Granted Dec 10, 2019·0 cites·13 claims
- 4667US10206995B2Live attenuated virus vaccines for la crosse virus and other bunyaviridaeUS HEALTH·Filed 2017·Granted Feb 19, 2019·0 cites·7 claims
- 4766US10456461B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusUS HEALTH·Filed 2018·Granted Oct 29, 2019·0 cites·12 claims
- 4866US10160957B2Development of dengue virus vaccine componentsUS HEALTH·Filed 2015·Granted Dec 25, 2018·0 cites·6 claims
- 4966USRE45123ERecombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesisUS GOVERNMENT·Filed 2013·Granted Sep 9, 2014·0 cites·10 claims
- 5054US7829102B2Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccinesUS HEALTH·Filed 2005·Granted Nov 9, 2010·0 cites·7 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen S. Whitehead files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →